🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/02/2007 | 42,12 | 42,20 | 41,89 | 42,04 | +0,25% | 0,75% | 6.874.146 |
| 13/02/2007 | 42,08 | 42,13 | 41,69 | 41,94 | +0,23% | 1,04% | 7.480.729 |
| 12/02/2007 | 41,98 | 42,21 | 41,70 | 41,84 | +0,07% | 1,23% | 9.276.896 |
| 09/02/2007 | 42,04 | 42,25 | 41,66 | 41,81 | -0,23% | 1,41% | 5.758.131 |
| 08/02/2007 | 42,00 | 42,70 | 41,80 | 41,91 | -0,77% | 2,14% | 7.576.726 |
| 07/02/2007 | 42,82 | 42,83 | 41,96 | 42,23 | -0,85% | 2,05% | 9.068.239 |
| 06/02/2007 | 42,69 | 42,73 | 42,19 | 42,60 | +0,13% | 1,27% | 8.284.126 |
| 05/02/2007 | 42,57 | 42,65 | 42,22 | 42,54 | -0,34% | 1,01% | 11.738.543 |
| 02/02/2007 | 43,05 | 43,23 | 41,90 | 42,68 | -0,89% | 3,10% | 15.398.474 |
| 01/02/2007 | 42,84 | 43,36 | 42,64 | 43,06 | +0,85% | 1,67% | 8.337.574 |
| 31/01/2007 | 42,84 | 43,02 | 42,46 | 42,70 | -0,36% | 1,31% | 10.228.585 |
| 30/01/2007 | 43,66 | 43,83 | 42,56 | 42,85 | -1,32% | 2,91% | 13.092.874 |
| 29/01/2007 | 44,07 | 44,11 | 43,23 | 43,43 | -1,04% | 1,99% | 7.784.125 |
| 26/01/2007 | 43,88 | 44,27 | 43,34 | 43,88 | -0,02% | 2,11% | 7.392.906 |
| 25/01/2007 | 43,90 | 44,42 | 43,63 | 43,89 | -0,48% | 1,80% | 8.482.512 |
| 24/01/2007 | 43,68 | 44,21 | 43,59 | 44,10 | +1,07% | 1,42% | 6.476.011 |
| 23/01/2007 | 43,44 | 43,86 | 43,23 | 43,64 | +0,95% | 1,45% | 8.743.988 |
| 22/01/2007 | 43,34 | 43,81 | 42,97 | 43,23 | -0,66% | 1,94% | 8.492.678 |
| 19/01/2007 | 43,76 | 44,05 | 43,35 | 43,51 | -0,31% | 1,59% | 9.909.050 |
| 18/01/2007 | 42,99 | 43,90 | 42,99 | 43,65 | +1,62% | 2,13% | 11.123.053 |
| 17/01/2007 | 42,89 | 43,16 | 42,65 | 42,95 | +0,13% | 1,18% | 8.045.391 |
| 16/01/2007 | 42,75 | 43,10 | 42,66 | 42,89 | +0,36% | 1,03% | 6.580.497 |
| 12/01/2007 | 42,44 | 43,02 | 42,29 | 42,74 | +1,20% | 1,73% | 9.872.579 |
| 11/01/2007 | 42,22 | 42,56 | 41,91 | 42,23 | +0,32% | 1,54% | 8.051.889 |
| 10/01/2007 | 41,84 | 42,36 | 41,63 | 42,10 | +0,55% | 1,73% | 7.949.080 |
| 09/01/2007 | 42,27 | 42,46 | 41,82 | 41,87 | -0,93% | 1,51% | 9.037.114 |
| 08/01/2007 | 41,18 | 42,48 | 41,18 | 42,26 | -0,02% | 3,15% | 7.384.522 |
| 05/01/2007 | 43,03 | 43,03 | 42,16 | 42,27 | -1,80% | 2,04% | 11.168.431 |
| 04/01/2007 | 41,62 | 43,37 | 41,62 | 43,04 | +2,48% | 4,20% | 13.115.930 |
| 03/01/2007 | 42,01 | 42,83 | 41,96 | 42,00 | +0,96% | 2,09% | 15.740.226 |